APA (7th ed.) Citation

C, B., R, F., M, L., E, D., FS, C., M, M., . . . M, D. (2021). Inhibition of tumor-associated macrophages by trabectedin improves the antitumor adaptive immunity in response to anti-PD-1 therapy. European journal of immunology, 51(11), 2677. https://doi.org/10.1002/eji.202149379

Chicago Style (17th ed.) Citation

C, Belgiovine, Frapolli R, Liguori M, Digifico E, Colombo FS, Meroni M, Allavena P, and D'Incalci M. "Inhibition of Tumor-associated Macrophages by Trabectedin Improves the Antitumor Adaptive Immunity in Response to Anti-PD-1 Therapy." European Journal of Immunology 51, no. 11 (2021): 2677. https://doi.org/10.1002/eji.202149379.

MLA (9th ed.) Citation

C, Belgiovine, et al. "Inhibition of Tumor-associated Macrophages by Trabectedin Improves the Antitumor Adaptive Immunity in Response to Anti-PD-1 Therapy." European Journal of Immunology, vol. 51, no. 11, 2021, p. 2677, https://doi.org/10.1002/eji.202149379.